FIELD: medicine.
SUBSTANCE: needle unit for subcutaneous injections comprises a number of needles and a connector, which can connect the above number of needles and a pressure injector element. Each of the needles has a passage configured to enable a therapeutic material flowing through it, and a tube comprising the number of openings along the needle tube, and having a closed end.
EFFECT: improved fixation of the delivered substance by generating a pressure required to load cells with a disturbed permeability of cell walls.
14 cl, 3 tbl, 35 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
MODIFIED NUCLEOSIDE, NUCLEOTIDE AND NUCLEIC ACID COMPOSITIONS | 2012 |
|
RU2649364C2 |
METHODS AND FORMULATIONS FOR CELLS TRANSFECTION | 2012 |
|
RU2624139C2 |
METHODS AND PRODUCTS FOR EXPRESSION OF PROTEINS IN CELLS | 2013 |
|
RU2711249C2 |
METHOD OF DELIVERING BIOLOGICALLY ACTIVE MACROMOLECULES INTO THE CELLS OF PLANTS | 2017 |
|
RU2663347C1 |
AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND APPLICATIONS THEREOF | 2018 |
|
RU2816240C2 |
METHODS AND PREPARATIONS FOR TRANSFECTION OF CELLS | 2012 |
|
RU2691027C2 |
SYRINGE DEVICES | 2016 |
|
RU2710493C2 |
DETERMINATION OF RATIO OF NUCLEIC ACIDS | 2018 |
|
RU2803339C2 |
Authors
Dates
2015-01-27—Published
2010-12-14—Filed